5 Results for "

HPK1-IN-3

" in MedChemExpress (MCE) Product Catalog:
Products (5)

5 Results for "HPK1-IN-3" in MCE Product Catalog:

Cat. No.: HY-138568
CAS No.: 2739844-34-7
Purity:  98.61%
Target:  

MAP4K

Research Areas:  

Inflammation/Immunology

HPK1-IN-3 is a potent and selective ATP-competitive hematopoietic progenitor kinase 1 (HPK1; MAP4K1) inhibitor with an IC50 of 0.25 nM. HPK1-IN-3 has IL-2 cellular potency with an EC50 of 108 nM in human peripheral blood mononuclear cells (PBMCs) .
loading...
    loading...
Cat. No.: HY-174357
Research Areas:  

Cancer

HPK1 ligand 3-dimethylph tetrahydropyridine is a Target Protein Ligand-Linker Conjugate. HPK1 ligand 3-dimethylph tetrahydropyridine can be used to synthesize PROTAC HPK1 Degrader-4 (HY-174135) .
loading...
    loading...
Cat. No.: HY-162816
Research Areas:  

Cancer

PROTAC HPK1 Degrader-3 is an orally active, PROTAC degrader that selectively targets HPK1, with a DC50 of 21.26 nM. PROTAC HPK1 Degrader-3 induces HPK1 degradation via the ubiquitin-proteasome system and forms a stable ternary complex with HPK1 and CRBN. It inhibits the SLP76 and NF-κB signaling pathways, enhances MAPK signal transduction, reverses the immunosuppressive factor-mediated inhibition of T cell cytokine secretion, and promotes the secretion of T cell immune cytokines. PROTAC HPK1 Degrader-3 suppresses tumor growth and enhances anti-PD-L1-mediated antitumor activity. It can be used in studies related to malignant tumors, such as colorectal cancer .
loading...
    loading...
Cat. No.: HY-174355
Research Areas:  

Cancer

HPK1 ligand 3 is a ligand for target protein for PROTAC that can be used to synthesize PROTAC HPK1 Degrader-4 (HY-174135) .
loading...
    loading...
Cat. No.: HY-149056A
CAS No.: 2415374-97-7
Purity:  99.49%
Target:  

MAP4K

Research Areas:  

Cancer

(3S,4R)-GNE-6893 is a potent and orally active HPK1 inhibitor. (3S,4R)-GNE-6893 can be used in research of cancer .
loading...
    loading...